FDA Adverse Event Injury Summary report: N

ADVANTA V12 COVERED STENT

MDR report key: 8308828 · Received February 5, 2019

Report

Report Number
3011175548-2019-00139
Event Type
Injury
Date Received
February 5, 2019
Report Date
February 5, 2019
Manufacturer
ATRIUM MEDICAL
Product Code
NIN
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A COMPLETE INVESTIGATION WAS NOT ABLE TO BE PERFORMED AS NO PRODUCT CODE, LOT NUMBER OR SAMPLE WAS PROVIDED. THE STUDY CONCLUDED CH-EVAS IS AN OFF-THE-SHELF SOLUTION TO TREAT JAAS WITH HIGH TECHNICAL SUCCESS.

Description of Event or Problem · 1

RECEIVED AN ARTICLE TITLED CHIMNEY TECHNIQUE IN COMBINATION WITH A SAC-ANCHORING ENDOGRAFT FOR JUXTARENAL AORTIC ANEURYSMS: TECHNICAL ASPECTS AND EARLY RESULTS. THE ARTICLE PRESENTED TECHNICAL ASPECTS AND EARLY CLINICAL RESULTS OF A MULTICENTER EXPERIENCE WITH CH-EVAS. PER THE ARTICLE ADVERSE EVENTS INCLUDED: ISCHEMIC EVENTS, ARTERIAL INJURY, BLEEDING (HEMORRHAGE AND ENDOLEAKS), AND OCCLUSION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
101746 ADVANTA V12 COVERED STENT STENT, RENAL NIN ATRIUM MEDICAL

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention